Exchange: NYSE·Updated 07:30 PM EDT

OACB Oaktree Acquisition Corp II - Ordinary Shares - Class A

$5.75
$0.13
(2.21%)
Today
Closed $5.75
$0.00
(0.00%)
After Hours
Mkt Cap$2.24B
Vol705,190.00

About OACB

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.
50

Neutral Sentiment

How do you feel about OACB?

Advertisement|Remove ads.